The dvm360® cardiology page is home to a plethora of resources involving the latest advancements in diagnosing, managing, and treating cardiology. From expert insights into the latest trends to interviews, videos, podcasts, news, and beyond, find out everything you need to know about cardiology here.
November 22nd 2024
Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs
October 26th 2024
The effect of hydration status on echocardiographic measurements of normal cats
September 1st 2008In a recent article (The Effect of Hydration Status on the Echocardiographic Measurements of Normal Cats, by Campbell, F.E. & Kittleson, M.D. J Vet Intern Med 2007), the authors examined the effect of hydration status on echocardio-graphic findings in normal cats.
LSU performs canine transcatheter closure of a PDA
November 14th 2007Baton Rouge - 11/14/07 - The first-time procedure for professors in the Louisiana State University School of Veterinary Medicine (LSU) has saved the life of a colleague's German Shepherd that had been suffering from congestive heart failure.
Mastering Management: Evaluating hypertension
January 1st 2007Most veterinary hospitals recommend geriatric pets receive once (or twice) yearly evaluations including an examination and blood testing. According to Dr. Bonnie Lefbom of Chesapeake Veterinary Cardiology Associates in Vienna, Va. that evaluation should also include a blood pressure measurement.
Thoracoscopic partial pericardectomy in the dog
November 1st 2006Pericardial effusion presents clinicians with a challenge when diagnosing the underlying cause, since the prognosis can be favorable in certain cases. Partial pericardectomy can be performed via thoracoscopy; and in select cases, this minimally invasive procedure can provide long-term relief of clinical signs.
Pimobendan: Understanding its cardiac effects in dogs with myocardial disease
October 1st 2006Pimobendan, a benzimidazole-pyridazinone drug, is classified as an inodilator because of its nonsympathomimetic, nonglycoside positive inotropic (through myocardial calcium sensitization) and vasodilator properties.